CompletedPhase 1NCT03104855

Clearance of 25-hydroxyvitamin D in Cystic Fibrosis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Washington
Principal Investigator
Ian de Boer, MD, MS
University of Washington
Intervention
d6-25-hydroxyvitamin D3(drug)
Enrollment
10 enrolled
Eligibility
18 years · All sexes
Timeline
20172023

Study locations (1)

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03104855 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials